CQS Cayman LP Purchases New Holdings in CME Group Inc (NASDAQ:CME)

CQS Cayman LP purchased a new stake in shares of CME Group Inc (NASDAQ:CME) in the second quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 176,709 shares of the financial services provider’s stock, valued at approximately $34,301,000. CME Group accounts for approximately 1.4% of CQS Cayman LP’s portfolio, making the stock its 14th largest position.

A number of other hedge funds and other institutional investors have also modified their holdings of CME. Parnassus Investments CA purchased a new position in CME Group in the second quarter worth about $544,292,000. Magellan Asset Management Ltd purchased a new position in shares of CME Group during the second quarter valued at approximately $418,297,000. Geode Capital Management LLC raised its holdings in shares of CME Group by 12.9% during the fourth quarter. Geode Capital Management LLC now owns 4,715,269 shares of the financial services provider’s stock valued at $885,776,000 after purchasing an additional 537,917 shares during the last quarter. Fiera Capital Corp raised its holdings in shares of CME Group by 17.0% during the second quarter. Fiera Capital Corp now owns 2,960,477 shares of the financial services provider’s stock valued at $574,658,000 after purchasing an additional 429,235 shares during the last quarter. Finally, FMR LLC raised its holdings in shares of CME Group by 5.7% during the first quarter. FMR LLC now owns 6,553,654 shares of the financial services provider’s stock valued at $1,078,600,000 after purchasing an additional 355,566 shares during the last quarter. 84.99% of the stock is owned by institutional investors.

Several research firms have recently weighed in on CME. Wells Fargo & Co boosted their price objective on shares of CME Group from $176.00 to $200.00 and gave the company a “market perform” rating in a report on Wednesday, July 3rd. BidaskClub lowered shares of CME Group from a “buy” rating to a “hold” rating in a research report on Thursday. Zacks Investment Research lowered shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 target price for the company. in a research report on Monday, May 27th. UBS Group boosted their target price on shares of CME Group from $191.00 to $214.00 and gave the company a “neutral” rating in a research report on Thursday, September 5th. Finally, Barclays boosted their target price on shares of CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a research report on Thursday, May 23rd. Three equities research analysts have rated the stock with a sell rating, six have issued a hold rating and seven have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $196.85.

Shares of CME traded up $0.42 during mid-day trading on Friday, reaching $205.80. The stock had a trading volume of 974,804 shares, compared to its average volume of 1,132,937. The firm has a market cap of $72.54 billion, a price-to-earnings ratio of 30.18, a PEG ratio of 4.51 and a beta of 0.19. CME Group Inc has a 12 month low of $161.05 and a 12 month high of $224.91. The business has a fifty day moving average of $211.25 and a 200 day moving average of $191.16. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.05 and a current ratio of 1.05.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.75 by $0.01. The business had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The company’s revenue was up 20.1% on a year-over-year basis. During the same period in the prior year, the business posted $1.74 earnings per share. On average, research analysts forecast that CME Group Inc will post 6.69 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Tuesday, September 10th will be given a $0.75 dividend. The ex-dividend date is Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.46%. CME Group’s payout ratio is currently 43.99%.

In related news, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $200.15, for a total transaction of $7,005,250.00. Following the sale, the chief executive officer now owns 79,057 shares of the company’s stock, valued at $15,823,258.55. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Sean Tully sold 7,200 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $223.13, for a total transaction of $1,606,536.00. Following the sale, the insider now directly owns 19,923 shares in the company, valued at approximately $4,445,418.99. The disclosure for this sale can be found here. Over the last quarter, insiders sold 59,626 shares of company stock valued at $12,255,934. Company insiders own 1.20% of the company’s stock.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Read More: How to invest in a bear market

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.